CADTH is seeking nominations for its Board of Directors, and expert and advisory committees. We are currently accepting applications from individuals with significant expertise in the Canadian health care system who are interested in helping support health care decision-makers in making informed…
Amid the growth in precision medicine, a new CADTH report unpacks the hype from hope about these technologies and highlights the issues that could influence their adoption
Tests that could alter traditional pathways for cancer care. Tools that offer access to genetic test results and ways to engage…
Three new reports from CADTH are bringing health care decision-makers valuable new insight on post–COVID-19 condition, also known as long COVID.
The reports include an environmental scan of specialized clinics and professional resources in Canada, an update of the evidence landscape for the…
CADTH is pleased to announce recent organizational changes that are strengthening the execution of the organization’s strategic ambitions and advancing life cycle health technology management.
As part of these changes, CADTH has merged its Pharmaceutical Reviews program and Medical Devices and…
We are pleased to announce that, after a hiatus in 2022, we are once again accepting nominations for our Recognition Awards. These 2 awards recognize achievement and excellence in Canada’s health technology assessment (HTA) community.
The Dr. Jill M. Sanders Award of Excellence in Health…
November 14 to 20
In celebration of Digital Health Week, CADTH is proud to share some of the evidence we have delivered to inform decisions about digital health technologies in categories that span artificial intelligence, smartphone apps, virtual care, and more.
Visit Our Digital Health Evidence…
Today, CADTH, on behalf of the Real-World Evidence Steering Committee, launched a public consultation to solicit feedback on a pan-Canadian guidance document that will inform the use of real-world evidence (RWE) that may be submitted for consideration in regulatory and reimbursement decision-making…
Today we are proud to mark World Evidence-Based Healthcare (EBHC) Day, a global initiative to highlight the critical role of evidence in improving health outcomes, enhancing clinical care, and informing policy .
The 2022 World EBHC Day campaign focuses on partnerships within the global evidence…
Six health technology assessment (HTA) bodies from 3 continents will join forces to collaborate on a range of topics to benefit people accessing health care around the world.
The signatories to the arrangement, who will continue to remain independent of one another, are:
National Institute for…
CADTH is pleased to announce the launch of its new Post-Market Drug Evaluation Program.
This important initiative fills a key gap in Canada’s drug safety and effectiveness landscape and is an exciting example of how CADTH is delivering on the “Innovate” pillar from its 2022-2025 Strategic Plan.…
We recently experienced problems with its website hosting platform that prevented users from downloading documents from cda-amc.ca – including draft reimbursement recommendations and stakeholder feedback forms.
The issue has been resolved and all documents on our website are now accessible to…
CADTH is pleased to announce the introduction of the Real-World Evidence (RWE) Guidance Working Group which reports to the Real-World Evidence Steering Committee. The objective of the Guidance Working Group is to develop clear and comprehensive guidance on the conduct, reporting, and appraising of…